These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23627681)

  • 21. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxybutynin therapy for generalized hyperhidrosis.
    Tupker RA; Harmsze AM; Deneer VH
    Arch Dermatol; 2006 Aug; 142(8):1065-6. PubMed ID: 16924061
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.
    Pariser DM; Krishnaraja J; Tremblay TM; Rubison RM; Love TW; McGraw BF
    J Drugs Dermatol; 2017 Feb; 16(2):127-132. PubMed ID: 28300854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure.
    Lembrança L; Wolosker N; de Campos JRM; Kauffman P; Teivelis MP; Puech-Leão P
    Ann Vasc Surg; 2017 Aug; 43():283-287. PubMed ID: 28478174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of topical agents and oxybutynin as a therapeutic modality for patients with both osmidrosis and hyperhidrosis.
    Varella AYM; Fukuda JM; Teivelis MP; Pinheiro LL; Mendes CA; Kauffman P; Campos JRM; Wolosker N
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):127-132. PubMed ID: 29641679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of oxybutynin use in treating facial hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; Campbell TP; Kauffman P; Campos JR; Puech-Leão P
    An Bras Dermatol; 2014; 89(6):912-6. PubMed ID: 25387496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxybutynin: dry days for patients with hyperhidrosis.
    Mijnhout GS; Kloosterman H; Simsek S; Strack van Schijndel RJ; Netelenbos JC
    Neth J Med; 2006 Oct; 64(9):326-8. PubMed ID: 17057269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary hyperhidrosis controlled with oxybutynin after unsuccessful surgical treatment.
    Wozniacki L; Zubilewicz T
    Clin Exp Dermatol; 2009 Dec; 34(8):e990-1. PubMed ID: 20055880
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxybutynin in primary hyperhidrosis: A long-term real-life study.
    Almeida ART; Ferrari F; Restrepo MVS; Rocha VB
    Dermatol Ther; 2020 Nov; 33(6):e14344. PubMed ID: 32981151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers.
    Del Boz J; Millán-Cayetano JF; Blázquez-Sánchez N; de Troya M
    Pediatr Dermatol; 2016 May; 33(3):327-31. PubMed ID: 27122197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders.
    Wolosker N; Krutman M; Campdell TP; Kauffman P; Campos JR; Puech-Leão P
    Einstein (Sao Paulo); 2012; 10(4):405-8. PubMed ID: 23386077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.
    Kamikava DYF; Wolosker N; Silva MFAD; Campos JRM; Puech-Leão P
    Clinics (Sao Paulo); 2021; 76():e2892. PubMed ID: 34190853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial study of transdermal oxybutynin for treating hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; Toledo-Pastrana T; Nieto-Guindo M; García-Montero P; de Troya-Martín M
    J Dermatol; 2017 Jun; 44(6):717-720. PubMed ID: 28106275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the long-term results of surgical treatment of palmar hyperhidrosis].
    Laín A; García-Casillas MA; Fanjul M; Corona C; Tardáguila A; Matute JA
    Cir Pediatr; 2010 Jul; 23(3):153-6. PubMed ID: 23155661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy.
    Costa Ada S; Leão LE; Succi JE; Perfeito JA; Filho Castelo A; Rymkiewicz E; Filho Aurelio Marchetti M
    Clinics (Sao Paulo); 2014 Feb; 69(2):101-5. PubMed ID: 24519200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.
    Attallah HS; El-Gilany AH; Youssef YEB; Abdelshaheed ME; Sharaf EFA
    Indian J Dermatol; 2022; 67(3):222-227. PubMed ID: 36386101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.